0113 2727560

Contact Us

Contact CPWY

Twitter Latest Tweets

Latest PSNC News

Drug Tariff Watch: April 2019 changes

The Preface lists additions, deletions and alterations to the Drug Tariff. Below is a quick summary of the changes due to take place from 1st April 2019. Part VIIIA additions Category A: Ketoconazole 200mg tablets (60) Category C: Baricitinib 2mg tablets (28) – Olumiant Baricitinib 4mg tablets (28) – Olumiant Budesonide 200micrograms/dose dry powder inhalation cartridge...

5 hours ago

March 2019 Price Concessions – 1st update

Department of Health and Social Care (DHSC) has today granted the following initial list of price concessions: Drug Pack Size Concession Price Alverine 60mg capsules 100 £2.82 Brimonidine 0.2% eye drops 5ml £3.20 Bumetanide 1mg tablets 28 £1.94 Candesartan 4mg tablets 7 £0.76 Carvedilol 6.25mg tablets 28 £0.83 Carvedilol 25mg tablets 28 £3.87 Co-careldopa 25/100mg...

22 hours ago

Quality Payments: Updated gateway criteria report now available

The NHS Business Services Authority (NHSBSA) has updated its weekly gateway criteria report, allowing community pharmacy contractors to check whether they have been assessed, using national datasets, as meeting four of the five gateway criteria (Advanced Services, NHS website, Community Pharmacy Patient Questionnaire (CPPQ) and NHSmail) – due to cyber security reasons, the report does not...

2 days ago

Managing complaints about prescription direction

‘Prescription direction’ occurs where a patient is directed by their GP practice to a certain pharmacy to have their prescription dispensed. The BMA, Pharmacy Voice and PSNC have published a joint statement stating that prescription direction should not take place. Prescription direction undermines a patient’s right to have a free choice between any community pharmacy, and damages trust and cooperation between healthcare professionals.

 

NHS England (which manages the contracts with GPs and pharmacies) and the General Medical Council and General Pharmaceutical Council (the professional regulators) all have a role in stepping in to challenge cases of prescription direction. They generally need to hear from patients before they will take action.

 

If any of your patients complain about undue pressure to use a particular pharmacy, you can use the Your Prescription Your Choice Leaflet to help them to easily register a complaint.

 

If you become aware that a patient has been subjected to prescription direction:

1. Explain that doctors and pharmacists across the country have agreed that this is not the right way to behave – patients should always be free to choose their pharmacy, and no-one should seek to undermine that right

2.  That if certain GPs or pharmacies locally are behaving in this way, that this needs to be reported so that something can be done to stop it

3.  Offer them the “Your Prescription Your Choice” form, explaining that it contains information about this problem and gives them the opportunity to report what has happened to them

4.  Advise them that the back half of the form can be detached and submitted to the appropriate body. They can submit the form themselves, or ask you to do it for them

5.  Encourage them to complete the form in the pharmacy, and say that you’ll send their form off for them, along with any other forms that you receive, to save them the cost of a stamp or phone call

 

Please respect the right of patients not to complain if they are uncomfortable in doing so. Please also recognise that you should treat any interactions with patients on this topic as confidential.

 

Once forms have been returned to you, the next steps are:

1.  Send the form to NHS England in all cases.

2.  If there is evidence that a GP may have acted inappropriately, a copy of the form should be sent to the General Medical Council

3.  If there is evidence that a pharmacist or pharmacy company may have acted inappropriately, a copy of the form should be sent to the General Pharmaceutical Council.

4.  We suggest that you keep a log of the forms that you have sent off

 

The full BMA, Pharmacy Voice and PSNC statement on prescription direction is available at: 

http://psnc.org.uk/wp-content/uploads/2013/07/BMA_PSNC_PV_prescription_direction_guidance_October_13.pdf

 

Your Prescription Your Choice Leaflet